TJ202

· TJ Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TJ202, covering 2025-04-24 to 2025-04-24. Get the full timeline:

Most recent: Clinical Trial Update: TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma [Phase 2]